References
- AnjumKShaguftaBIAbbasSQCurrent status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: a reviewBiomed Pharmacother20179268168928582760
- ParasramkaSTalariGRosenfeldMGuoJVillanoJLProcarbazine, lomustine and vincristine for recurrent high-grade gliomaCochrane Database Syst Rev201771CD01177328744879
- FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
- Cancer Facts & Figures 2017Atlanta, GAAmerican Cancer Society2017
- BrandesAATosoniAFranceschiEReniMGattaGVechtCGlioblastoma in adultsCrit Rev Oncol Hematol200867213915218394916
- GlaserTHanIWuLZengXTargeted nanotechnology in glioblastoma multiformeFront Pharmacol2017816628408882
- TosiUMarnellCSChangRAdvances in molecular imaging of locally delivered targeted therapeutics for central nervous system tumorsIn J Mol Sci2017182E351
- ReniMMazzaEZanonSGattaGVechtCJCentral nervous system gliomasCrit Rev Oncol Hematol201711321323428427510
- SeystahlKPapachristodoulouABurghardtIBiological role and therapeutic targeting of TGF-β3 in glioblastomaMol Cancer Ther20171661177118628377490
- ZhouJTienACAlbertaJAA sequentially priming phosphorylation cascade activates the gliomagenic transcription factor olig2Cell Rep201718133167317728355568
- LiYLinTLuoYA smart and versatile theranostic nanomedicine platform based on nanoporphyrinNat Commun20145471225158161
- Di CoratoRBéalleGKolosnjaj-TabiJCombining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomesACS Nano2015932904291625695371
- PasparakisGManourasTVamvakakiMArgitisPHarnessing photochemical internalization with dual degradable nanoparticles for combinatorial photo-chemotherapyNat Commun20145362324710504
- MuXZhangFKongCEGFR-targeted delivery of DOX-loaded Fe3O4@polydopamine multifunctional nanocomposites for MRI and antitumor chemo-photothermal therapyInt J Nanomedicine2017122899291128435266
- LianHYHuMLiuCHYamauchiYWuKCWHighly biocompatible, hollow coordination polymer nanoparticles as cisplatin carriers for efficient intracellular drug deliveryChem Commun (Camb)201248425151515322514015
- ShiehFKWangSCYenCLImparting functionality to biocatalysts via embedding enzymes into nanoporous materials by a de novo approach: size-selective sheltering of catalase in metal−organic framework microcrystalsJ Am Chem Soc2015137134276427925781479
- LiangYHLiuCHLiaoSHCosynthesis of cargo-loaded hydroxyapatite/alginate core-shell nanoparticles (HAP@Alg) as pH-responsive nanovehicles by a pre-gel methodACS Appl Mater Interfaces20124126720672723151216
- BastakotiBPHsuYCLiaoSHInorganic-organic hybrid nanoparticles with biocompatible calcium phosphate thin shells for fluorescence enhancementChem Asian J2013861301130523526653
- McnamaraKTofailSANanosystems: the use of nanoalloys, metallic, bimetallic, and magnetic nanoparticles in biomedical applicationsPhys Chem Chem Phys20151742279812799526024211
- TassaCShawSYWeisslederRDextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapyAcc Chem Res2011441084285221661727
- LutzJFStillerSHothAKaufnerLPisonUCartierROne-pot synthesis of pegylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agentsBiomacromolecules20067113132313817096542
- KohlerNFryxellGEZhangMA bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agentsJ Am Chem Soc2004126237206721115186157
- MasoudiAMadaah HosseiniHRShokrgozarMAAhmadiROghabianMAThe effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agentInt J Pharm20124331–212914122579990
- MaDGuanJDénomméeSEnrightGVeresTSimardBMultifunctional nano-architecture for biomedical applicationsChem Mater200618719201927
- BanZBarnakovYALiFGolubaVOO’ConnoCJThe synthesis of core–shell iron@gold nanoparticles and their characterizationJ Mater Chem2005154346604662
- ChenMYamamuroSFarrellDMajetichSAGold-coated iron nanoparticles for biomedical applicationsJ Appl Phys2003931075517553
- ZhouTWuBXingDBio-modified Fe3O4 core/Au shell nanoparticles for targeting and multimodal imaging of cancer cellsJ Mater Chem2011222470477
- BrullotWValevVKVerbiestTMagnetic-plasmonic nanoparticles for the life sciences: calculated optical properties of hybrid structuresNanomedicine20128555956821945901
- ZhouHChoiSIZouFCytotoxicity and gene expression in sarcoma 180 cells in response to spiky magnetoplasmonic supraparticlesACS Appl Mater Interfaces2014622196801968925369231
- ZhouHZouFKohKLeeJMultifunctional magnetoplasmonic nanomaterials and their biomedical applicationsJ Biomed Nanotechnol201410102921294925992424
- EspinosaADiCRKolosnjaj-TabiJFlaudPPellegrinoTWilhelmCDuality of iron oxide nanoparticles in cancer therapy: amplification of heating efficiency by magnetic hyperthermia and photothermal bimodal treatmentACS Nano20161022436244626766814
- LiYuntaoLiuJingZhongYuejiaoBiocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivoInt J Nanomedicine201162805281922131827
- DuYZhangDLiuHLaiRThermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9BMC Biotechnol200998419804631
- TzonevaRFaucheuxNGrothTWettability of substrata controls cell-substrate and cell-cell adhesionsBiochim Biophys Acta20071770111538154717804166
- WongAJBignerSHBignerDDKinzlerKWHamiltonSRVogelsteinBIncreased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplificationProc Natl Acad Sci U S A19878419689969033477813
- van den BentMJBrandesAARamplingRRandomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034J Clin Oncol20092781268127419204207
- LassmanABRossiMRRaizerJJMolecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Clin Cancer Res200511217841785016278407
- DokalaAThakurSSExtracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discoveryOncogene201736172337234427775071
- HerbstRSLangerCJEpidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancersSemin Oncol200229292736
- ChenXZhuXLiLInvestigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor IIInt J Pharm2013456249950723999222
- JoDHKimJHLeeTGKimJHSize, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseasesNanomedicine20151171603161125989200
- WangHZhaoXGuoCAptamer-dendrimer bioconjugates for targeted delivery of miR-34a expressing plasmid and antitumor effects in non-small cell lung cancer cellsPLoS One2015109e013913626406332
- GuoJGaoXSuLAptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug deliveryBiomaterials201132318010802021788069
- TaghaviSNiaAHAbnousKRamezaniMPolyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cellsInt J Pharm20175161–230131227840158